Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

Validation of a novel WHO tool to detect and characterize Autism Spectrum Disorder

FY 2018-19

Summary
The World Health Organization (WHO) is currently revising the 10th edition of the International Classification of Diseases (ICD-10), and has developed a new assessment tool for individuals with Autism Spectrum Disorder (ASD). Reliable and valid diagnostic assessment tools are needed to improve access to care for individuals with ASD because they often have special needs. The aim of this study is to field test the WHO tool internationally to assess how useful, reliable, and accurate the new tool is compared to standard tests. This is a cross-cultural study led and coordinated in Canada. A total of 60 children and youth (aged 0 months to 17 years) with a suspected or established diagnosis of ASD will be recruited in five countries (India, Sri Lanka, Brazil, United Kingdom, and Italy). At the first appointment, a clinician will assess participants using the novel WHO tool, collect information to make a diagnosis, and complete an assessment of the tool's clinical usefulness. A second clinician will test the same person within two weeks to see if the test produces the same result over time. A third clinician will administer standard tests (Leiter-3, Vineland Adaptive Behavior Scales-II) of intellectual and every-day abilities. The development of a valid and accessible diagnostic tool may reduce health differences and substantially improve the accurate identification and proper description of individuals with ASD. This project is useful for all Canadians in that it has the potential to improve identification of people with Autism in areas where special services are not available. This data will also be provided to the WHO Secretariat for ongoing ICD development.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
404082
Name
Lemay Kyle R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Validation of a novel WHO tool to detect and characterize Autism Spectrum Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Autism Spectrum Disorder; Diagnosis; Field Test; Healthcare Policy; International Classification Of Diseases (Icd-11); Psychometrics
Abstract
The World Health Organization (WHO) is currently revising the 10th edition of the International Classification of Diseases (ICD-10), and has developed a new assessment tool for individuals with Autism Spectrum Disorder (ASD). Reliable and valid diagnostic assessment tools are needed to improve access to care for individuals with ASD because they often have special needs. The aim of this study is to field test the WHO tool internationally to assess how useful, reliable, and accurate the new tool is compared to standard tests. This is a cross-cultural study led and coordinated in Canada. A total of 60 children and youth (aged 0 months to 17 years) with a suspected or established diagnosis of ASD will be recruited in five countries (India, Sri Lanka, Brazil, United Kingdom, and Italy). At the first appointment, a clinician will assess participants using the novel WHO tool, collect information to make a diagnosis, and complete an assessment of the tool's clinical usefulness. A second clinician will test the same person within two weeks to see if the test produces the same result over time. A third clinician will administer standard tests (Leiter-3, Vineland Adaptive Behavior Scales-II) of intellectual and every-day abilities. The development of a valid and accessible diagnostic tool may reduce health differences and substantially improve the accurate identification and proper description of individuals with ASD. This project is useful for all Canadians in that it has the potential to improve identification of people with Autism in areas where special services are not available. This data will also be provided to the WHO Secretariat for ongoing ICD development.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lemay, Kyle R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
University of Ottawa - $105,000 Grant (2018-19) | Canada Spends